BioMaxima Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 115


  • Stock Symbol
  • BMX

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $3.72
  • (As of Thursday Closing)

BioMaxima General Information


Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Stock Exchange
Corporate Office
  • Ul. Vetterów 5
  • Lublin, 20-277
  • Poland
+48 81 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMaxima Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.72 $3.80 $3.67 - $6.79 $15.6M 4.19M 4.95K $0.04

BioMaxima Financials Summary

In Thousands,
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 19,497 21,874 29,995 34,032
Revenue 10,790 32,247 20,472 15,714
EBITDA 910 8,420 3,808 2,894
Net Income 186 6,474 2,651 2,038
Total Assets 16,712 16,968 15,247 12,801
Total Debt 2,083 1,329 4,252 3,337
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioMaxima Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioMaxima‘s full profile, request access.

Request a free trial

BioMaxima Executive Team (2)

Name Title Board Seat Contact Info
Lukasz Urban Chief Executive Officer & President
Henry Lewczuk Vice President
To view BioMaxima’s complete executive team members history, request access »

BioMaxima Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMaxima Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biocorp Polska 28-Nov-2016 0000000000 00000 Biotechnology 00000 000
Qias Med 23-Nov-2016 0000000000 Diagnostic Equipment
Istar 15-Jun-2016 0000000000 Diagnostic Equipment
Roco Sistem 31-Mar-2013 0000000000 Commodity Chemicals 00000 000
Emapol 27-Jun-2012 Merger/Acquisition 00.000 Diagnostic Equipment 00000 000
You’re viewing 5 of 6 acquisitions. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »